Vol. 30, No. 2, 2018 249 Received December 12, 2016, Revised April 10, 2017, Accepted for publication May 6, 2017 Corresponding author: Mu-Hyoung Lee, Department of Dermatology, Kyung Hee University… Click to show full abstract
Vol. 30, No. 2, 2018 249 Received December 12, 2016, Revised April 10, 2017, Accepted for publication May 6, 2017 Corresponding author: Mu-Hyoung Lee, Department of Dermatology, Kyung Hee University Medical Center, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea. Tel: 82-2-958-8512, Fax: 82-2-969-6538, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology Hilari-Carbonell H, et al. Folliculocystic and collagen hamartoma of tuberous sclerosis complex. J Am Acad Dermatol 2012;66:617-621. 3. Nathan N, Wang JA, Li S, Cowen EW, Haughey M, Moss J, et al. Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus. J Am Acad Dermatol 2015;73:802-808. 4. Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci 2011;4:51. 5. Zolli C, Rodrigues MM, Shannon GM. Unusual eyelid involvement in tuberous sclerosis. J Pediatr Ophthalmol 1976;13:156-158.
               
Click one of the above tabs to view related content.